Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests. The drug, ...

New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...

Separate study finds GLP-1 medicines combined with bariatric surgery may significantly reduce risk of serious cardiovascular ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...

For the first time, scientists have pitted the two most popular weight loss drugs against each other in a direct competition ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed pounds, data suggests. The drug, which contains the active ingredient semaglutide, works by reducing food ...

The drug, which contains the active ingredient semaglutide ... a clinical trial found it reduced the risk of having a heart attack, stroke or heart disease death by 37% in people with obesity ...